eudragit-e has been researched along with nimodipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haibing, H; Jijun, F; Lishuang, X; Shu, Z; Xiaoguang, T; Xiaoli, W; Xing, T; Xingna, Z | 1 |
| Funke, A; Hörmann, TR; Khinast, JG; Makert, C; Rehrl, J; Schaden, LM; Scheibelhofer, O | 1 |
2 other study(ies) available for eudragit-e and nimodipine
| Article | Year |
|---|---|
Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion.
Topics: Biological Availability; Calcium Channel Blockers; Drug Carriers; Drug Stability; Hot Temperature; Nimodipine; Polymethacrylic Acids; Pyrrolidines; Solubility; Tablets; Vinyl Compounds | 2011 |
Sensitivity of a continuous hot-melt extrusion and strand pelletization line to control actions and composition variation.
Topics: Drug Compounding; Drug Liberation; Hot Melt Extrusion Technology; Hypromellose Derivatives; Methylmethacrylates; Nimodipine | 2019 |